Contec Bio: Adsorbed Tetanus Vaccine Receives Drug Registration Certificate

Contec Bio announced that its wholly-owned subsidiary, Beijing Minhai Biotechnology Co., Ltd., received the “Drug Registration Certificate” issued by the National Medical Products Administration today for the adsorptive tetanus vaccine developed by the company.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin